Efficient generation of functional pancreatic β‐cells from human induced pluripotent stem cells

Abstract Background Insulin‐secreting cells have been generated from human embryonic or induced pluripotent stem cells (iPSCs) by mimicking developmental processes. However, these cells do not always secrete glucose‐responsive insulin, one of the most important characteristics of pancreatic β‐cells. We focused on the importance of endodermal differentiation from human iPSCs in order to obtain functional pancreatic β‐cells. Methods A six‐stage protocol was established for the differentiation of human iPSCs to pancreatic β‐cells using defined culture media without feeders or serum. The effects of CHIR99021, a selective glycogen synthase kinase‐3β inhibitor, were examined in the presence of fibroblast growth factor 2, activin, and bone morphogenetic protein 4 (FAB) during definitive endodermal induction by immunostaining for SRY (sex determining region Y)‐box 17 (SOX17) and Forkhead box protein A2 (FOXA2). Insulin secretion was compared between the last stage of monolayer culture and spheroid culture conditions. Cultured cells were transplanted under kidney capsules of streptozotocin‐diabetic non‐obese diabetic–severe combined immunodeficiency mice, and blood glucose levels were measured once a week. Immunohistochemical analyses were performed 4 and 12 weeks after transplantation. Results Addition of CHIR99021 (3 μmol/L) in the presence of FAB for 2 days improved endodermal cell viability, maintaining the high SOX17‐positive rate. Spheroid formation after the endocrine progenitor stage showed more efficient insulin secretion than did monolayer culture. After cell transplantation, diabetic mice had lower blood glucose levels, and islet‐like structures were detected in vivo. Conclusion Functional pancreatic β‐cells were generated from human iPSCs. Induction of definitive endoderm and spheroid formation may be key steps for producing these cells.